Search This Blog

Friday, August 3, 2018

Alnylam Buy rating reiterated by Chardan


Today, Chardan Capital reiterated its Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) with a price target of $180.00.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)